Skip to main content
. 2022 Jan 13;4(2):e393–e402. doi: 10.1016/j.asmr.2021.10.016

Table 1.

Serious Adverse Events (Drop-Out Cases) in the 2 Groups

Case No. Adverse Event
Theracurmin group
 6 Brain bleeding
Placebo group
 8 Fracture and Infection
 27 Cholecystitis and Dermatitis
 35 Infection and Dermatitis